Skip to main content
logo
Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
43.84
+2.16 (5.18%)
At close: Nov 20, 2025, 4:00 PM EST
44.00
+0.16 (0.36%)
After-hours: Nov 20, 2025, 7:40 PM EST

Rigel Pharmaceuticals Revenue

Rigel Pharmaceuticals had revenue of $69.46M in the quarter ending September 30, 2025, with 25.59% growth. This brings the company's revenue in the last twelve months to $282.08M, up 79.13% year-over-year. In the year 2024, Rigel Pharmaceuticals had annual revenue of $179.28M with 54.71% growth.

Revenue (ttm)
$282.08M
Revenue Growth
+79.13%
P/S Ratio
2.64
Revenue / Employee
$1,719,976
Employees
164
Market Cap
795.75M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024179.28M63.40M54.71%
Dec 31, 2023115.88M140.00K0.12%
Dec 31, 2022115.74M-22.99M-16.57%
Dec 31, 2021138.74M30.12M27.72%
Dec 31, 2020108.62M49.33M83.21%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings

RIGL News

More News